Subject(s)

Coronavirus Infections/complications , Pneumonia, Viral/complications , Tuberculosis, Pulmonary/complications , Adult , Aged , Antitubercular Agents/therapeutic use , Antiviral Agents/therapeutic use , Azithromycin/therapeutic use , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Cohort Studies , Coinfection , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Drug Combinations , Emigrants and Immigrants , Female , Humans , Hydroxychloroquine/therapeutic use , Lopinavir/therapeutic use , Lung/diagnostic imaging , Male , Middle Aged , Mortality , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/drug therapy , Ritonavir/therapeutic use , SARS-CoV-2 , Tomography, X-Ray Computed , Tuberculosis/complications , Tuberculosis/diagnosis , Tuberculosis/drug therapy , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy , COVID-19 Drug Treatment